These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Brinton RD Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751 [TBL] [Abstract][Full Text] [Related]
3. The neurology of menopause. Henderson VW Neurologist; 2006 May; 12(3):149-59. PubMed ID: 16688016 [TBL] [Abstract][Full Text] [Related]
4. Effects of hormone replacement therapy on cognitive aging and dementia risk in postmenopausal women: a review of ongoing large-scale, long-term clinical trials. Zec RF; Trivedi MA Climacteric; 2002 Jun; 5(2):122-34. PubMed ID: 12051107 [TBL] [Abstract][Full Text] [Related]
5. Prognostic features of menopausal and postmenopausal applicants for life insurance. Schiefeling M J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866 [TBL] [Abstract][Full Text] [Related]
6. [Effect of hormone replacement therapy during the climacteric on cerebrovascular diseases]. Römer T; Foth D; Griewing B Z Arztl Fortbild Qualitatssich; 2000 Apr; 94(3):199-204. PubMed ID: 10802894 [TBL] [Abstract][Full Text] [Related]
7. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence. Harman SM; Naftolin F; Brinton EA; Judelson DR Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750 [TBL] [Abstract][Full Text] [Related]
8. [Menopause and hormone replacement therapy]. Tóth KS Orv Hetil; 2000 Mar; 141(11):547-56. PubMed ID: 10741167 [TBL] [Abstract][Full Text] [Related]
9. Comparative cardiovascular effects of different progestins in menopause. Rosano GM; Fini M Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197 [TBL] [Abstract][Full Text] [Related]
10. Prevention of Alzheimer's disease, cerebrovascular disease and dementia in women: the case for menopause hormone therapy. Davey DA Neurodegener Dis Manag; 2017 Feb; 7(1):85-94. PubMed ID: 28074678 [TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy and the risk of stroke. Follow-up of a population-based cohort in Sweden. Falkeborn M; Persson I; Terént A; Adami HO; Lithell H; Bergström R Arch Intern Med; 1993 May; 153(10):1201-9. PubMed ID: 8388207 [TBL] [Abstract][Full Text] [Related]
12. Hormone therapy and cognitive function: is there a critical period for benefit? Maki PM Neuroscience; 2006; 138(3):1027-30. PubMed ID: 16488547 [TBL] [Abstract][Full Text] [Related]
13. Incidence of dementia in long-term hormone users. Petitti DB; Crooks VC; Chiu V; Buckwalter JG; Chui HC Am J Epidemiol; 2008 Mar; 167(6):692-700. PubMed ID: 18218608 [TBL] [Abstract][Full Text] [Related]
14. Incidence and subtypes of dementia in three elderly populations of central Spain. Bermejo-Pareja F; Benito-León J; Vega S; Medrano MJ; Román GC; J Neurol Sci; 2008 Jan; 264(1-2):63-72. PubMed ID: 17727890 [TBL] [Abstract][Full Text] [Related]
15. [Hormone replacement Up-to-date. Hormone replacement therapy and brain function]. Mori K; Takeda M Clin Calcium; 2007 Sep; 17(9):1349-54. PubMed ID: 17767023 [TBL] [Abstract][Full Text] [Related]
16. Interactions between melatonin and estrogen may regulate cerebrovascular function in women: clinical implications for the effective use of HRT during menopause and aging. Harrod CG; Bendok BR; Hunt Batjer H Med Hypotheses; 2005; 64(4):725-35. PubMed ID: 15694689 [TBL] [Abstract][Full Text] [Related]
18. [Hormone replacement therapy and cardiovascular risk in menopausal women]. Simon T; Jaillon P Arch Mal Coeur Vaiss; 2001 Feb; 94(2):132-8. PubMed ID: 11265551 [TBL] [Abstract][Full Text] [Related]
19. Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study. Barnes DE; Alexopoulos GS; Lopez OL; Williamson JD; Yaffe K Arch Gen Psychiatry; 2006 Mar; 63(3):273-9. PubMed ID: 16520432 [TBL] [Abstract][Full Text] [Related]
20. [Dementia: risk and protective factors with special consideration of gender and hormone replacement therapy]. Stoppe G Z Arztl Fortbild Qualitatssich; 2000 Apr; 94(3):217-22. PubMed ID: 10802897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]